Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 178.80
+3.30 (1.88%)
Feb 20, 2025, 5:24 PM IDT
Novolog (Pharm-Up 1966) Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 902 | 726 | 1,409 | 1,504 | 1,423 | 783 | Upgrade
|
| Market Cap Growth | -15.32% | -48.50% | -6.30% | 5.66% | 81.80% | 100.06% | Upgrade
|
| Enterprise Value | 881 | 674 | 1,470 | 1,449 | 1,385 | 664 | Upgrade
|
| Last Close Price | 1.77 | 1.35 | 2.60 | 2.72 | 2.75 | 1.50 | Upgrade
|
| PE Ratio | - | - | 29.66 | 35.54 | 35.52 | 77.22 | Upgrade
|
| Forward PE | - | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 | Upgrade
|
| PS Ratio | 0.52 | 0.44 | 0.93 | 1.20 | 1.26 | 0.78 | Upgrade
|
| PB Ratio | 2.39 | 1.83 | 3.03 | 3.50 | 4.81 | 2.97 | Upgrade
|
| P/TBV Ratio | 11.66 | 10.37 | 13.19 | 9.06 | 19.23 | 14.99 | Upgrade
|
| P/FCF Ratio | 20.47 | 5.62 | 22.31 | 28.51 | 43.30 | 10.24 | Upgrade
|
| P/OCF Ratio | 7.40 | 3.63 | 10.62 | 18.03 | 24.33 | 7.72 | Upgrade
|
| EV/Sales Ratio | 0.51 | 0.41 | 0.98 | 1.15 | 1.22 | 0.66 | Upgrade
|
| EV/EBITDA Ratio | 5.66 | 5.42 | 15.60 | 15.81 | 17.28 | 10.80 | Upgrade
|
| EV/EBIT Ratio | 13.42 | 12.50 | 18.90 | 20.87 | 24.07 | 16.56 | Upgrade
|
| EV/FCF Ratio | 19.98 | 5.23 | 23.28 | 27.46 | 42.13 | 8.68 | Upgrade
|
| Debt / Equity Ratio | 0.52 | 0.54 | 0.46 | 0.39 | 0.52 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | 1.27 | 1.46 | 1.86 | 1.55 | 1.62 | 2.04 | Upgrade
|
| Debt / FCF Ratio | 4.61 | 1.67 | 3.37 | 3.16 | 4.69 | 2.07 | Upgrade
|
| Asset Turnover | 0.56 | 0.63 | 0.64 | 0.56 | 0.52 | 0.52 | Upgrade
|
| Inventory Turnover | 5.54 | 6.74 | 7.07 | 4.98 | 4.26 | 4.56 | Upgrade
|
| Quick Ratio | 0.83 | 0.84 | 0.87 | 0.91 | 0.84 | 0.85 | Upgrade
|
| Current Ratio | 0.97 | 0.96 | 0.98 | 1.03 | 0.99 | 0.98 | Upgrade
|
| Return on Equity (ROE) | -1.00% | -9.15% | 11.38% | 12.35% | 14.50% | 5.48% | Upgrade
|
| Return on Assets (ROA) | 1.41% | 1.29% | 2.06% | 1.94% | 1.66% | 1.29% | Upgrade
|
| Return on Capital (ROIC) | 6.93% | 5.24% | 7.63% | 8.29% | 8.25% | 9.47% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.83% | 8.94% | 11.41% | 11.58% | 12.70% | 9.18% | Upgrade
|
| Earnings Yield | -0.67% | -5.79% | 3.37% | 2.81% | 2.82% | 1.29% | Upgrade
|
| FCF Yield | 4.89% | 17.78% | 4.48% | 3.51% | 2.31% | 9.76% | Upgrade
|
| Dividend Yield | 2.20% | 2.17% | 2.53% | 3.44% | 0.94% | 2.86% | Upgrade
|
| Payout Ratio | 0.00% | - | 67.14% | 75.62% | 29.95% | 152.86% | Upgrade
|
| Buyback Yield / Dilution | 0.33% | 0.94% | -0.14% | -9.08% | -22.06% | -10.54% | Upgrade
|
| Total Shareholder Return | 2.54% | 3.12% | 2.39% | -5.64% | -21.12% | -7.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.